Neuroblastoma

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Neuroblastoma is unique in its biological heterogeneity. As a result, it is crucial that the therapies selected for its treatment are appropriate according to the patient's classification based on several risk factors, including the patient's age, staging, and the grade of the tumor's biological malignancy. Surgery is one of the key options in the multidisciplinary therapies, with surgeries for neuroblastoma classified into three categories: Radical primary resection, open biopsy, and radical second-look operations. It is necessary to select the appropriate surgery on an individual basis. Recently, the Japan Neuroblastoma Study Group (JNBSG) has been performing clinical studies using a classification system that includes three risk groups (low, intermediate, and high) based on the risk classifications of the Children's Oncology Group (COG). The surgical guidelines combine the low and intermediate groups to create two groups of patients: The low- and intermediate-risk group and the high-risk group.

Original languageEnglish
Title of host publicationOperative General Surgery in Neonates and Infants
PublisherSpringer Japan
Pages365-370
Number of pages6
ISBN (Electronic)9784431558767
ISBN (Print)9784431558743
DOIs
Publication statusPublished - Jun 23 2016
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Neuroblastoma'. Together they form a unique fingerprint.

Cite this